Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nucleophilic residues are specific amino acid side chains within a protein that possess electron-rich functional groups, such as the thiol of cysteine, the amine of lysine, or the hydroxyl of serine and tyrosine [1, 3]. These residues are critical for biological function, often serving as catalytic centers in enzymes or as sites for essential post-translational modifications like phosphorylation and ubiquitination [3, 12]. In the context of drug discovery, they are the primary sites for covalent inhibitors, which utilize electrophilic "warheads" to form permanent chemical bonds with the residue's nucleophilic center [7, 10]. This mechanism of action allows for prolonged target engagement and high potency, even against proteins with shallow or otherwise "undruggable" binding pockets [7, 8]. However, the ubiquity of these residues across the proteome necessitates high selectivity in drug design to avoid off-target reactivity and associated toxicities [9, 10]. Consequently, "nucleophilic residues" represents a broad chemical classification of reactive sites within proteins rather than a single, discrete therapeutic target [14].
Drugs target these residues through covalent bond formation, where the nucleophilic group on the amino acid side chain (such as a thiol or amine) attacks an electrophilic warhead on the drug molecule, resulting in irreversible or slowly reversible inhibition of the protein's activity.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nucleophilic residue.